Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022

Emerg Infect Dis. 2023 Apr;29(4):822-825. doi: 10.3201/eid2904.221268. Epub 2023 Mar 14.

Abstract

We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination boosters to elderly and frail persons seems justified.

Keywords: COVID-19; Italy; SARS-CoV-2; Verona; cohort study; coronavirus disease; coronaviruses; cumulative incidence; elderly; frail persons; incidence; pandemic; prevalence; reported data; respiratory infections; sampling data; serologic testing; vaccine; viruses; zoonoses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • COVID-19* / epidemiology
  • Cohort Studies
  • Cross-Sectional Studies
  • Humans
  • Italy / epidemiology
  • SARS-CoV-2*